Ironwood Pharmaceuticals (IRWD) Non Operating Income (2010 - 2026)
Ironwood Pharmaceuticals (IRWD) posted Non Operating Income of -$7.4 million for Q1 2026, down 16.55% sequentially from -$6.4 million in Q4 2025, and down 3.31% YoY from -$7.7 million in Q1 2025.
Ironwood Pharmaceuticals (IRWD) Non Operating Income (2010 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has reported Non Operating Income for 17 years, with the latest figure at -$7.4 million in Q1 2026.
- Quarterly Non Operating Income fell 3.31% year-over-year to -$7.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$28.7 million (up 1.08% YoY) and the FY2025 annual result came in at -$28.5 million, down 1.97% from the prior year.
- Non Operating Income declined to -$7.4 million in Q1 2026 per IRWD's latest filing, from -$6.4 million in the prior quarter.
- Over five years, Non Operating Income peaked at $6.9 million in Q2 2023 and troughed at -$8.3 million in Q3 2024.
- A 5-year average of -$3.8 million and a median of -$6.4 million in 2025 frame the typical range for Non Operating Income.
- The widest YoY moves for Non Operating Income: up 517.38% in 2023, down 664.23% in 2023.
- Over 5 years, Non Operating Income stood at $3.9 million in 2022, then tumbled by 285.26% to -$7.2 million in 2023, then declined by 3.69% to -$7.5 million in 2024, then grew by 15.29% to -$6.4 million in 2025, then fell by 16.55% to -$7.4 million in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered -$7.4 million, -$6.4 million, and -$7.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Ironwood Pharmaceuticals | 679.81 Mn | 600.69 Mn | - | -5.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.58 Mn |
| Mar 31, 2026 | -7.40 Mn |
| Dec 31, 2025 | -6.35 Mn |
| Sep 30, 2025 | -7.46 Mn |
| Jun 30, 2025 | -7.50 Mn |
| Mar 31, 2025 | -7.16 Mn |
| Dec 31, 2024 | -7.50 Mn |
| Sep 30, 2024 | -8.27 Mn |
| Jun 30, 2024 | -6.10 Mn |
| Mar 31, 2024 | -6.06 Mn |
| Dec 31, 2023 | -7.23 Mn |
| Sep 30, 2023 | -8.09 Mn |
| Jun 30, 2023 | 6.92 Mn |
| Mar 31, 2023 | 5.76 Mn |
| Dec 31, 2022 | 3.90 Mn |
| Sep 30, 2022 | 1.43 Mn |
| Jun 30, 2022 | -1.87 Mn |
| Mar 31, 2022 | -1.38 Mn |
| Dec 31, 2021 | -10.34 Mn |
| Sep 30, 2021 | -5.50 Mn |